Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7568798 | 0.83 | ALDH1A1 (0.43) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL5699062 | 0.80 | ALDH1A1 (0.41) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL2686734 | 0.74 | ALDH1A1 (0.50) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL132156 | 0.74 | ALDH1A1 (0.50) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL22555588 | 0.72 | ALDH1A1 (0.48) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL9703821 | 0.69 | ALDH1A1 (0.54) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL10636470 | 0.68 | ALDH1A1 (0.52) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL19091741 | 0.68 | ALDH1A1 (0.52) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL2869579 | 0.67 | LMNA (0.46) | ALDH1A1TDP1CYP3A4TSHRL3MBTL1 | |
| SCHEMBL29001284 | 0.67 | LMNA (0.46) | ALDH1A1TDP1CYP3A4TSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6518447-B2 | Reacting 2,3-dimethyl-2-butene with a hydrogenchlorosilane compound in presence of aluminum chloride to form thexylchlorosilanes | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-02-11 | — | — | US | claimed |
| EP-1238980-B1 | Silyl (meth)acrylates having bulky substituent group and preparation thereof | SHINETSU CHEMICAL CO (JP) | 2006-06-14 | — | — | EP | disclosed |
| EP-1203772-B1 | Thexylchlorosilanes, their manufacture and use | SHINETSU CHEMICAL CO (JP) | 2006-01-11 | — | — | EP | disclosed |
| US-6518447-B2 | Reacting 2,3-dimethyl-2-butene with a hydrogenchlorosilane compound in presence of aluminum chloride to form thexylchlorosilanes | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-02-11 | — | — | US | disclosed |
| US-6498264-B2 | REACTING A CHLOROSILANE COMPOUND WITH ACRYLIC OR METHACRYLIC ACID IN THE PRESENCE OF A BASIC COMPOUND; PROTECTIVE HYDROLYSABLE COATINGS FOR SHIP BOTTOMS; NONTOXIC; POLLUTION CONTROL; KINETICS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-12-24 | — | — | US | disclosed |
| US-20020128503-A1 | Silyl (meth)acrylates having bulky substituent group and preparation thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-09-12 | — | — | US | disclosed |
| EP-1238980-A1 | Silyl (meth)acrylates having bulky substituent group and preparation thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-09-11 | — | — | EP | disclosed |
| US-20020055647-A1 | Thexylchlorosilanes and making process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-05-09 | — | — | US | disclosed |
| EP-1203772-A2 | Thexylchlorosilanes, their manufacture and use | Shin-Etsu Chemical Co., Ltd. (JP) | 2002-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128503-A1 | Silyl (meth)acrylates having bulky substituent group and preparation thereof | SMS, MASTL, ACR | ALDH1A1 791/4885TDP1 3651/4885CYP3A4 873/4885 |
| US-20020055647-A1 | Thexylchlorosilanes and making process | LSS, SCLY, TET2 | ALDH1A1 1900/4885TDP1 2919/4885CYP3A4 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.